Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
申请人:Institut National de la Sante et de la Recherche Medicale (INSERM)
公开号:US10729770B2
公开(公告)日:2020-08-04
The present invention relates to ClpB expressing bacteria and their impact on obesity. The present invention relates to bacterial ClpB protein and ClpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one ClpB expressing bacterium as well as probiotics not expressing ClpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.
本发明涉及 ClpB 表达细菌及其对肥胖症的影响。本发明涉及细菌 ClpB 蛋白和 ClpB 表达细菌及其对饮食失调的影响。本发明还涉及包含针对至少一种 ClpB 表达细菌的抗生素的组合物以及不表达 ClpB 蛋白的益生菌及其在治疗或预防进食障碍中的用途。本发明还涉及用于确定受试者是否可能对治疗饮食失调症的方法产生反应的诊断工具,以及针对饮食失调症的免疫方法。